Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children

Pediatric Pulmonology

Volumn 47, Issue 1, 2012, Pages 27-35

  Kersten, Elin T G ^a   Van Leeuwen, Janneke C ^a   Brand, Paul L P ^b   Duiverman, Eric J ^c   De Jongh, Frans H C ^a   Thio, Bernard J ^a   Driessen, Jean M M ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

allergic rhinitis; asthma; exercise induced asthma; fluticasone; quality of life

Indexed keywords

FLUTICASONE FUROATE; NITRIC OXIDE; PLACEBO;

ADOLESCENT; ALLERGIC RHINITIS; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BRONCHOSPASM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPISTAXIS; EXERCISE; EXERCISE INDUCED BRONCHOCONSTRICTION; FEMALE; FLU LIKE SYNDROME; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PEDIATRIC ASTHMA QUALITY OF LIFE QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD;

EID: 84155165282     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21511     Document Type: Article

References (32)

1. Global Initiative for Asthma. GINA Report, Global Strategy for Asthma Management and Prevention. Update 2009 [accessed June 20, 2010]. Available from http://www.ginasthma.com/.
2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Couwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben KA, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D,. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63: 8-160. (Pubitemid 351357811)
3. Stewart MG,. Identification and management of undiagnosed and undertreated allergic rhinitis in adults and children. Clin Exp Allergy 2008; 38: 751-760. (Pubitemid 351550664)
4. Braunstahl GJ,. United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 2009; 6: 652-654.
5. Taramarcaz P, Gibson PG,. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev 2003; 4: CD003570.
6. Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P,. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms. J Asthma 2008; 45: 754-757.
7. Watson WT, Becker AB, Simons FE,. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91: 97-101. (Pubitemid 23042185)
8. Corren J, Adinoff AD, Buchmeier AD, Irvin CG,. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90: 250-256.
9. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R,. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996; 98: 274-282.
10. Stelmach R, do Patrocinio TN, Ribeiro M, Cukier A,. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128: 3140-3147. (Pubitemid 41698633)
11. Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R,. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005; 60: 875-881. (Pubitemid 40813808)
12. Nair A, Vaidyanathan S, Clearie K, Williamson P, Meldrum K, Lipworth BJ,. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. Allergy 2010; 65: 359-367.
13. Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P,. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 2001; 108: 921-928. (Pubitemid 33151544)
14. Henriksen JM, Wenzel A,. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130: 1014-1018. (Pubitemid 15186156)
15. Cockcroft D, Davis B,. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol 2009; 103: 363-369.
16. Merikallio VJ, Mustalahti K, Remes ST, Valovirta EJ, Kaila M,. Comparison of quality of life between asthmatic and healthy school children. Pediatr Allergy Immunol 2005; 16: 332-340. (Pubitemid 40868490)
17. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ,. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-329.
18. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR,. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907. (Pubitemid 29519356)
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J,. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
20. Quanjer PH, Borsboom GJ, Brunekreef B, Zach M, Forche G, Cotes JE, Sanchis J, Paoletti P,. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995; 19: 135-142.
21. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
22. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M,. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35-46. (Pubitemid 26100501)
23. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W, Kuna P,. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008; 121: 383-389. (Pubitemid 351215167)
24. Brannan JD,. Bronchial hyperresponsiveness in the assessment of asthma control: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138: 11S-17S.
25. Doull J, Sandall D, Smith S, Schreiber J, Freezer NJ, Holgate ST,. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5' monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatr Pulmonol 1997; 23: 404-411. (Pubitemid 27287495)
26. Scadding GK, Keith PK,. Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data. Expert Opin Pharmacother 2008; 9: 2707-2715.
27. Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS,. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005; 128: 1910-1920. (Pubitemid 41507521)
28. Scichilone N, Arrigo R, Paterno A, Santagata R, Impellitteri S, Braido F, Baiardini I, Battaglia S, Walter CG, Bellia V,. The effect of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma. J Asthma 2011; 48: 41-47.
29. Pedroletti C, Lundahl J, Alving K, Hedlin G,. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma. Pediatr Allergy Immunol 2008; 19: 219-226. (Pubitemid 351499166)
30. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR,. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003; 111: 313-320. (Pubitemid 36228552)
31. Kleinjan A, Willart M, van Nimwegen M, Leman K, Hoogsteden HC, Hendriks RW, Lambrecht BN,. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin Exp Allergy 2010; 40: 494-504.
32. McCormack PL, Scott LJ,. Fluticasone furoate: intranasal use in allergic rhinitis. Drugs 2007; 67: 1905-1915. (Pubitemid 47347403)